QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT04898543 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Solid Tumor

Interventions

BIOLOGICAL: M-CENK, Suspension for Infusion, Cryopreserved (M-CENK) (Cohort 2 part B)
BIOLOGICAL: N-803 (Cohort 2 part B)
OTHER: Apheresis collection of MNCs (part A)

Sponsor

ImmunityBio, Inc.